FDA-Inspected Site

APHROZONE INTERNATIONAL, INC.

1 FDA inspection is on record for APHROZONE INTERNATIONAL, INC. in Los Angeles, United States.

483· Form 483 issued

Los Angeles, United States · Last updated July 10, 2026

Overview

  • 1 FDA inspection is on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2018-09-17.

At a glance

Inspections

1

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
17 Sep 2018Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

17 Sep 2018
21 CFR 211.150

Written distribution procedure

Cited by Liming Zhang

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.150Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind APHROZONE INTERNATIONAL, INC.'s 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat